Keyphrases
Liver Disease
100%
Transcriptome Analysis
100%
Constitutive Androstane Receptor
100%
Cholestasis
100%
Biliary Atresia
57%
Liver
42%
Drug Metabolism
42%
Metabolic Genes
42%
Receptor Activation
28%
Nonalcoholic Steatohepatitis
28%
Alcoholic Hepatitis
28%
Virus
14%
Viral Infection
14%
Comparative Analysis
14%
High-throughput Sequencing
14%
Overlapping Genes
14%
Paralysis
14%
Protective Effect
14%
Clinical Outcomes
14%
Therapeutic Agents
14%
Beneficial Effects
14%
Clinical Significance
14%
High-level Expression
14%
Unintended Consequences
14%
Mouse Liver
14%
Diet-induced
14%
Receptor Targets
14%
Steatosis
14%
Human Samples
14%
Therapeutic Outcome
14%
Gene Programs
14%
Molecular Signature
14%
Detoxification Genes
14%
Liver Transcriptome
14%
Comparative Transcriptome Analysis
14%
Gene Profile
14%
Receptor Activity
14%
Liver Toxicity
14%
Injury Type
14%
Pharmacological Approaches
14%
Transcriptomic Changes
14%
Partial Hepatectomy
14%
Lay Summary
14%
Cytochrome P450 2D6 (CYP2D6)
14%
Acetaminophen-induced Hepatotoxicity
14%
HCV Infection
14%
HBV Infection
14%
Medicine and Dentistry
Disease
100%
Gene Expression Profiling
100%
Liver Disease
100%
Cholestasis
100%
Constitutive Androstane Receptor
100%
Biliary Atresia
57%
Drug Metabolism
42%
Liver Toxicity
28%
Nonalcoholic Fatty Liver
28%
Hepatitis B Virus
28%
Alcohol Liver Disease
28%
Infection
14%
Transcriptome
14%
Injury
14%
Transcriptomics
14%
Paracetamol
14%
Detoxication
14%
Paralysis
14%
Steatosis
14%
Virus Infection
14%
CYP2B6
14%
Overlapping Gene
14%
Partial Hepatectomy
14%
Zoxazolamine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Liver Disease
100%
Constitutive Androstane Receptor
100%
Cholestasis
100%
Bile Duct Atresia
57%
Mouse
42%
Drug Metabolism
42%
Hepatotoxicity
28%
Nonalcoholic Fatty Liver
28%
Transcriptome
28%
Hepatitis B Virus
28%
Alcohol Liver Disease
28%
Infection
14%
Injury
14%
Paralysis
14%
Steatosis
14%
Detoxication
14%
Paracetamol
14%
Virus Infection
14%
CYP2B6
14%
Zoxazolamine
14%